Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
![Thumbnail](/xmlui/bitstream/handle/10566/5516/40268_2020_Article_302.pdf.jpg?sequence=4&isAllowed=y)
View/ Open
Date
2020Author
Mulubwa, Mwila
Griesel, Heletje Aletta
Mugabo, Pierre E.
Metadata
Show full item recordAbstract
The pharmacokinetics of vancomycin, a drug used for the treatment of methicillin-resistant Staphylococcus
aureus (MRSA), varies between paediatric and adult patients.
The objective of this study was to assess the pharmacokinetics of vancomycin in preterm neonates and determine
the optimum dose regimen.